Instructions for Baralgin m (Metamizole sodium)
English product name
Baralgin® M
Release form Baralgin m
500 mg/1 ml r/d/w and b/m: amp. 5 ml 5 ampoules.
Description Baralgin m:
Solution for in/in and in/m administration in the form of transparent, colourless or slightly coloured liquid.
1 ml
sodium methamisole: 500 mg
Auxiliary substances: water d/i - up to one ml.
5 ml - dark glass ampoules (five) - uncoated cell contour plastic packaging (1) - cardboard packs.
ATC codes
N02BB02 Metamizole sodium
Clinical-pharmacological groups / Group affiliation
Analgesic non-narcotic preparation
Active substance
sodium metamisole
Pharmacotherapy group Metamizole sodium
Analgesic nonarcotic agent
Storage Conditions
The drug Metamizole sodium should be stored in a place inaccessible to children, protected from light at temperatures from 8 ° C to 25 ° C.
Best before date Baralgin m
The shelf life is four years. Do not use the drug Metamizole sodium after the expiry date indicated on the package.
Pharmacological effect:
Analgesic non-narcotic preparation of the pyrazolon group having analgesic, antipyretic and spasmolytic action. Its mechanism of action has not been finalized.
The available data suggest that methamizol and its major metabolite (4N-methylaminoantipyrin [4-MAA]) have a central and peripheral mechanism of action. In doses higher than therapeutic doses, anti-inflammatory effects may be achieved, possibly by suppressing prostaglandin synthesis.
Testimony:
- severe acute or chronic pain syndrome in traumas and in the postoperative period,
- colic,
- oncological diseases and other conditions,
- in which other therapeutic methods of treatment are contraindicated;
- Fever resistant to other treatments.
Method of use, course and dosage:
V/V, V/M deep in muscle.
Parenteral administration of the drug Metamizole sodium is shown only when it is impossible to take it inside. It is recommended to warm the drug to body temperature before administration.
Adults and adolescents over the age of fifteen: 1.0-2.0 ml (500-1000 mg) of methamizol solution (b/m or b/b) is recommended as a single dose. The maximum single dose is 1000 mg (two ml). The maximum daily dose is 4 ml (2000 mg), divided into 2-3 injections per day.
For children aged 3-11 months (body weight more than five kg to 9 kg), the preparation is administered only in/m in a dose of 50-100 mg per 10 kg body weight (0.1-0.2 ml of solution 500 mg/ml). A single dose can be divided into two to three injections.
Use in liver disorders
In patients with kidney impairment, the rate of removal of sodium methamisole is slowed, so it is necessary to avoid repeated use of the drug. There is no long-term experience. No dose correction is required for short-term therapy.
Terms of Sale
The drug Metamizole sodium is prescription.
Application in elderly patients
In older patients, lower doses should be used due to possible reduction in the elimination of metabolites of methamizol from the body.
Use in children Baralgin m
Contraindications: Children under three months of age or less than five kg of body weight (there is insufficient scientific evidence for this group of children); Children between 3 and 12 months of age (B/V only).
- Nosology Baralgin m (ICD codes)
- K80
- Gallstone disease [cholelitiasis] (incl. hepatic colic)
- N23
- Renal colic unspecified
- R10.4
- Other and unspecified abdominal pain (colic)
- R50
- Fever of uncertain origin
- R52.0
- Acute pain
- R52.2
- Other persistent pain (chronic)
- T14.9
- Injury unspecified
- Z98.8
- Other refined post-surgical conditions
